Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1998-01-20 to 1998-06-26
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Suboptimal GLP quality; adequate coherence between data, comments and conclusions; deviations to guideline; vehicle control inappropriate (saline although test item was dissolved in distilled water)
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1998
Report date:
1998

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EPA OTS 798.5395 (In Vivo Mammalian Cytogenics Tests: Erythrocyte Micronucleus Assay)
Deviations:
yes
Remarks:
from EC B.12: top-dose did not induce overt toxicity and was below the recommendation of 2000 mg/kg
GLP compliance:
yes
Remarks:
No laboratory compliance certificate. No analytical certificate for test item. Test item characterization insufficient. No study director-signed GLP declaration.
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Ammonium perchlorate
EC Number:
232-235-1
EC Name:
Ammonium perchlorate
Cas Number:
7790-98-9
Molecular formula:
ClHO4.H3N
IUPAC Name:
ammonium perchlorate
Details on test material:
- Substance type: MCP
- Physical state: solid powder*
- Nominal purity: 99.8%*
- Lot/batch No.: 03907LF
- Expiration date of the lot/batch: not indicated
- Stability under test conditions: not indicated but stability verified in drinking water*
- Storage condition of test material: at room temperature

*: not reported (insufficient test item characterization), but available for the same batch in other studies under 7.8.2

Test animals

Species:
mouse
Strain:
CD-1
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River
- Age at study initiation: approx. 9-11 weeks (not specified)
- Weight at study initiation: 24-32 g
- Assigned to test groups randomly: yes, by body weight
- Fasting period before study: no
- Housing: 5/cage for F, individual for M
- Diet (e.g. ad libitum): ad lib
- Water (e.g. ad libitum): ad lib
- Acclimation period: not indicated

ENVIRONMENTAL CONDITIONS not indicated

IN-LIFE DATES: not indicated

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
- Sterile distilled water
- Justification for choice of solvent/vehicle: highly soluble
- Concentration of test material in vehicle: 50-400 g/L (-> top dose above water solubility limit)
- Amount of vehicle (if gavage or dermal): 10 mL/kg
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:
dissolved freshly before dosing
Duration of treatment / exposure:
see below
Frequency of treatment:
Range-finding: up to three times at 24-h intervals
Main test: three times at 24-h intervals
Post exposure period:
all sacrifices 24-h after last dose
Doses / concentrations
Remarks:
Doses / Concentrations:
62.5, 125, 250, 500 and 1000 mg/kg/day
Basis:
actual ingested
main test
No. of animals per sex per dose:
5 (main test)
Control animals:
other: physiological saline, invalid (distilled water was the vehicle)
Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): clastogen
- Route of administration: i.p.
- Doses / concentrations: 20 mg/kg once

Examinations

Tissues and cell types examined:
Femoral bone marrow - polychromatic and normochromatic erythrocytes
Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION: see results

DETAILS OF SLIDE PREPARATION:
Smears -> slides; MGG staining

METHOD OF ANALYSIS:
range-finding + main test: random observation of 1000 erythrocytes for myelotoxicity determination (polychromatic and normochromatic)
main test only: random observation of 1000 polychromatic erythrocytes for micronucleus determination
Evaluation criteria:
Compared statistically and vs. background frequencies
Statistics:
ANOVA, Student t-test

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
yes
Remarks:
bone marrow: none; general: lethal at 2000 mg/kg
Vehicle controls validity:
other: valid but wrong vehicle
Negative controls validity:
not applicable
Positive controls validity:
valid
Additional information on results:
RESULTS OF RANGE-FINDING STUDY
- 5/6 dead within 30 min of 1st dose at 4000 mg/kg;
- 4/6 dead within 24h of 1st dose at 2000 mg/kg; survivors dosed twice at 1000 and 500 mg/kg: no death and no myelotoxic effect
- 4000 and 2000 mg/kg were respectively above and around the solubility limit (~200 g/L)
- Rationale for exposure: none indicated, but serum perchlorate levels evidenced in human studies after oral or inhalative exposures

RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): no, within background frequencies
- Ratio of PCE/NCE (for Micronucleus assay): within background frequencies
- Appropriateness of dose levels and route: yes
- Statistical evaluation: significant increase for positive control only

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative
Absence of in vivo genotoxic potential in a standard assay at up to 1000 mg/kg (non-toxic dose, but close to the lethal dose of 2000 mg/kg).
Executive summary:

Ammonium perchlorate was provided to groups of 5 male and 5 female mice by gavage in distilled water, at up to 1000 mg/kg/day on three consecutive days. The bone marrow from each mouse was assessed for micronucleus formation at sacrifice. Cyclophosphamide was administered i.p. to additional mice, as a positive control.

  • Vehicle control was invalid (wrong vehicle: physiological saline) but negative. This validates the study design's specificity.
  • The positive control induced a significant, 8 to 10-fold increase in micronucleus frequency but no myelotoxicity. This validates the study design's sensitivity.
  • Ammonium perchlorate induced no significant increase in micronucleus frequency or myelotoxicity vs. vehicle controls or historical frequencies. The top-dose was expected to be toxic as it was close to the lethal dose of 2000 mg/kg (after single dosing), but induced no toxicity.